13 Results for "

PAR-2-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "PAR-2-IN-2" in MCE Product Catalog:

Referencia número: HY-169817
No. CAS: 313986-65-1
PAR-2-IN-2 (compound P-596) is a protease-activated receptor 2 (PAR-2) inhibitor with an IC50 of 10.79 μM for SLIGKV and an IC50 of greater than 200 μM for Trypsin .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-138558
No. CAS: 1690176-75-0
Pureza:  99.79%
Target:  

Drug Intermediate

Áreas de investigación:  

Inflammation/Immunology Cancer

PAR-2-IN intermediate-1 is a drug intermediate that can be used to synthesize inhibitors of the PAR-2 signaling pathway .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-E70226
No. CAS: 71965-46-3
Synonyms: CTSS
Human Cathepsin S (CTSS) is a cysteine protease with elastinolytic activity. Human Cathepsin S is inhibited by cysteine protease inhibitors such as E-64 (HY-15282) and cystatin C. Human Cathepsin S cleaves substrates including elastin, TGF-β1, Myelin basic protein (HY-P1821), PAR2, SIRT1, collagen 18A1, FKN, and MHC-II invariant chain fragments, thereby driving processes such as elastic matrix degradation, TGF-β1 signaling, demyelination, PAR2-mediated calcium mobilization, NF-κB activation, hepatic fibrosis, immune homeostasis regulation, and antigen presentation. Human Cathepsin S can be used in the research of cardiovascular diseases, chronic kidney diseases, autoimmune diseases, tumors, Alzheimer's disease, and obesity .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-120528A
Pureza:  99.86%
Áreas de investigación:  

Inflammation/Immunology Cancer

GB-110 hydrochloride is a potent, orally active, and nonpeptidic protease activated receptor 2 (PAR2) agonist. GB-110 hydrochloride selectively induces PAR2-mediated intracellular Ca 2+ release in HT29 cells with an EC50 of 0.28 μM .
loading...
    loading...
Referencia número: HY-P990483
Synonyms: PAR650097

Target:  

Inhibitory Antibodies

Áreas de investigación:  

Inflammation/Immunology

Anti-PAR2 Antibody (PAR650097) is a CHO-expressed human antibody that targets PAR2. Anti-PAR2 Antibody (PAR650097) has a huIgG1 heavy chain and huλ light chain, with a predicted molecular weight (MW) of 144.1 kDa. The isotype control for Anti-PAR2 Antibody (PAR650097) can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Referencia número: HY-171096
No. CAS: 2378159-28-3
Áreas de investigación:  

Neurological Disease

PAR2 modulator-1 is a biased protease-activated receptor 2 (PAR2) inhibitor. PAR2 modulator-1 blocks the PAR2-dependent MAPK signaling pathway with an IC50 value of 8.5 μM, without altering the PAR2-dependent Ca 2+ signaling pathway. PAR2 modulator-1 blocks pain responses induced by PAR2 agonists. PAR2 modulator-1 can be used in the research of chronic pain .
loading...
    loading...
Referencia número: HY-120528
No. CAS: 1252806-70-4
Áreas de investigación:  

Inflammation/Immunology Cancer

GB-110 is a potent, orally active, and nonpeptidic protease activated receptor 2 (PAR2) agonist. GB-110 selectively induces PAR2-mediated intracellular Ca 2+ release in HT29 cells with an EC50 of 0.28 μM .
loading...
    loading...
Referencia número: HY-138951
No. CAS: 1835734-92-3
Áreas de investigación:  

Inflammation/Immunology Cancer

AY77 is a calcium-biased PAR2 agonist. AY77 shows an EC50 of 0.17 and 2 nM in PAR2-mediated the activation in the Gq pathway and recruitment of β-arrestin-2, respectively. AY77 potently induces intracellular Ca 2+ release .
loading...
    loading...
Referencia número: HY-P1312
No. CAS: 245329-01-5
Áreas de investigación:  

Others

LRGILS-NH2 is a reverse-sequence protease-activated receptor-2 (PAR-2)-inactive, negative control, and SLIGRL-NH2 is a PAR-2-activating peptide .
loading...
    loading...
Referencia número: HY-P1312A
Áreas de investigación:  

Others

LRGILS-NH2 TFA is a reverse-sequence protease-activated receptor-2 (PAR-2)-inactive, negative control, and SLIGRL-NH2 is a PAR-2-activating peptide .
loading...
    loading...
Referencia número: HY-111214
No. CAS: 880546-17-8
Áreas de investigación:  

Inflammation/Immunology

K-14585 is a peptide competitive PAR2 antagonist. K-14585 inhibits PAR2-dependent IL-8 production, NF-κB phosphorylation, and p38 signaling. K-14585 reduces SLIGKV (PAR2 agonist peptide)-induced Ca 2+ mobilisation in primary human keratinocytes .
loading...
    loading...
Referencia número: HY-P11840
Áreas de investigación:  

Inflammation/Immunology

KLK5-IN-1 is a selective kallikrein 5 (KLK5) inhibitor with an IC50 of 14 nM and a Ki of 11 nM. KLK5-IN-1 reduces KLK5-mediated PAR2-dependent calcium mobilization. KLK5-IN-1 improves epithelial barrier integrity. KLK5-IN-1 can be used in research related to atopic dermatitis and Netherton syndrome .
loading...
    loading...
Referencia número: HY-180244
No. CAS: 1359416-20-8
Áreas de investigación:  

Cancer

P2L-003 is a selective PAR2 antagonist with an IC50 of 0.62 μM in HT-29 cells. P2L-003 blocks PAR2-mediated Ca 2+ mobilization without affecting PAR1, PAR4, or ATP-mediated signaling and dose-dependently suppresses the downstream MAPK signaling cascades, including ERK1/2 and p38 phosphorylation. P2L-003 can be used for colon cancer research .
loading...
    loading...
  • 1